OpenNeedle Ask your own

Question explored with the scientific record

Answered on this page ↓

Does vitamin K reduce risks from Taking vitamin D

Oct 30, 2026 · 3 sources used · OpenNeedle synthesis
The short version: vitamin K is a plausible partner to vitamin D for the calcium-handling side, but no human trial here shows it prevents the harms of vitamin D, and the vitamin D risks themselves are mostly dose-dependent.

The mechanism is real. Vitamin D raises matrix Gla protein, the vitamin K-dependent protein that keeps calcium out of arteries, two to three fold [1]. Prolonged vitamin D at just 400 IU a day was linked to more hypercalciuria, kidney stones, hypercalcemia, and vascular lesions [1]. That is the case for pairing them.

The direct test is thin. In a 3-year trial, vitamin K1 plus calcium and vitamin D versus calcium and vitamin D alone showed no difference in coronary calcium overall, though adherent participants and those with existing calcium had less progression [3]. That is a subgroup signal, not a proven benefit.

FindingWhat it shows
Vitamin D raises MGP 2-3x [1]Mechanism for K pairing
D at 400 IU/day linked to stones, high calcium [1]Risk is dose-related
K1 vs K1+calcium+D, coronary calcium [3]No overall difference; subgroup only
K status and mortality in heart disease [2]Association, not causation

My call: vitamin K is low-risk and mechanistically sensible alongside vitamin D, but the human outcome evidence is a subgroup signal, not proof. Confidence: low.

Keep digging

Sources used 3

  1. Matrix-GLA-Protein and Vascular Calcification: Can Diet Influence the Consequences of Matrix GLA Protein Inactivation? A Review International Journal of Innovative Research in Medical Science (2021) Thin

    Dietary factors, particularly vitamin K and vitamin D interactions, modulate Matrix GLA Protein (MGP) carboxylation and related calcification pathways, with evidence from the reviewed literature suggesting diet can influence vascular calcification risk in CKD and other settings.

    DOI: 10.23958/ijirms/vol06-i10/1235
  2. The coincidence of low vitamin K status and high expression of growth differentiation factor 15 may indicate increased mortality risk in stable coronary heart disease patients Nutrition, Metabolism and Cardiovascular Diseases (2021) Thin

    This prospective study in stable coronary heart disease patients shows that concurrent high desphospho-uncarboxylated matrix Gla protein (dp-ucMGP; low vitamin K status) and high growth differentiation factor-15 (GDF-15) at baseline identify a markedly increased risk of all-caus…

    DOI: 10.1016/j.numecd.2020.09.015
  3. Vitamin K supplementation and progression of coronary artery calcium in older men and women The American Journal of Clinical Nutrition (2009) Thin

    A 3-year, double-blind randomized trial tested whether daily vitamin K1 (phylloquinone) supplementation (500 μg) with calcium and vitamin D slows progression of coronary artery calcium (CAC) in older adults; overall intention-to-treat showed no CAC progression difference, but ad…

    DOI: 10.3945/ajcn.2008.27338

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →